Hennessy Advisors Inc Paratek Pharmaceuticals, Inc. Transaction History

Hennessy Advisors Inc

  • $3.26 Billion
  • Q4 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2018

Jul 20, 2018
SELL
$10.2 - $13.9 $259,997 - $354,311
-25,490 Closed
0 $0
Q1 2018

May 02, 2018
BUY
$12.65 - $18.85 $322,448 - $480,486
25,490 New
25,490 $331,000

Others Institutions Holding PRTK

# of Institutions
4
Shares Held
1.54M
Call Options Held
0
Put Options Held
0
View Full List

About Paratek Pharmaceuticals, Inc.

PRTK Quotes by TradingView
  • Ticker PRTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,862,500
  • Description
  • Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...
More about PRTK
Track This Portfolio

Track Hennessy Advisors Inc Portfolio

Follow Hennessy Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hennessy Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Hennessy Advisors Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email